Currently, there are no targeted therapies for cSCC; however, several agents are under investigation, including epidermal growth receptor factor (EGFR) inhibitors and programmed cell death protein 1 (PD-1) inhibitors [65,66,67,68,69]. The gene discussed is PDCD1; the disease is skin squamous cell carcinoma.